Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer
User The Lancet on YouTube,
Dr James Harding presents the findings of their paper, published in The Lancet Oncology on 2 June 2023: Zanidatamab for HER2-ampl…